SINAE YOO: Open Payments
NPI 1073897351 · VOORHEES, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$839 in 44 payments from 17 companies in 2025. Trend: 2023 $85 · 2024 $376 · 2025 $839
Food & beverage: $757Education: $82
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 7 | $165 |
| Exact Sciences Corporation | 4 | $91 |
| Amgen Inc. | 4 | $65 |
| AstraZeneca Pharmaceuticals LP | 4 | $64 |
| Novo Nordisk Inc | 4 | $63 |
| Lundbeck LLC | 3 | $55 |
| Axsome Therapeutics, Inc. | 3 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Xeris Pharmaceuticals, Inc. | 2 | $35 |
| ABBVIE INC. | 2 | $35 |
Products named: REXULTI, The Cologuard Plus Collection Kit, Veozah, Auvelity, REPATHA, BREZTRI, KEVEYIS, VRAYLAR.
Industry payments across NJ — which companies pay providers there.
